title: Cyclooxygenase-2 expression in esophageal epithelium before and after photodynamic therapy for Barrett's esophagus with high-grade dysplasia or intramucosal carcinoma.
abstract: Cyclooxygenase-2 expression is upregulated in Barrett's esophagus and esophageal adenocarcinoma. Photodynamic therapy using porfimer sodium can result in ablation of dysplasia and intramucosal carcinoma, eradication of Barrett's esophagus, and restitution of squamous epithelium. The aim of this study was to determine the effect of photodynamic therapy on cyclooxygenase-2 expression in esophageal epithelium. Paired pre- and post-photodynamic therapy biopsy samples from the same anatomical levels of 20 individuals who had undergone photodynamic therapy for Barrett's esophagus with high-grade dysplasia and/or intramucosal carcinoma were immunostained using a cyclooxygenase-2 monoclonal antibody. Cyclooxygenase-2 expression was graded in squamous epithelium, Barrett's esophagus, and neoplasia (if present) as follows: grade 0 (no staining), grade 1 (staining in 1-10% of cells), grade 2 (staining in 11-90% of cells), and grade 3 (staining in >90% of cells). Pre-photodynamic therapy median cyclooxygenase-2 expression was grade 2 (range 1-3) in neoplastic foci and grade 1 (range 1-3) in nondysplastic Barrett's esophagus (P=0.0009 for pairwise comparison). With the exception of a few cells staining in the basal epithelial layers, median cyclooxygenase-2 expression was graded as 0 (similar to controls) in both pre-photodynamic therapy squamous epithelium and post-photodynamic therapy neosquamous epithelium. This was significantly lower when compared to either neoplastic foci (P<0.0001) or nondysplastic Barrett's esophagus (P<0.0001) pre-photodynamic therapy. Notably, in four patients with post-photodynamic therapy recurrent neoplasia, cyclooxygenase-2 expression returned to elevated levels. Cyclooxygenase-2 expression is elevated in Barrett's esophagus with high-grade dysplasia or intramucosal carcinoma prior to photodynamic therapy. Following successful photodynamic therapy, cyclooxygenase-2 expression in neosquamous epithelium returns to a low baseline level similar to that observed in native esophageal squamous epithelium. Post-photodynamic therapy neoplastic recurrence is associated with elevated cyclooxygenase-2 expression. Prospective studies should determine whether cyclooxygenase inhibitors have a role as adjuvant therapy to prevent recurrence of Barrett's esophagus following endoscopic therapy.
authors.affiliation: Gastrointestinal Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA, patrick.yachimski@vanderbilt.edu
authors.forename: Patrick
authors.initials: P
authors.lastname: Yachimski
authors.forename: Mari
authors.initials: M
authors.lastname: Mino-Kenudson
authors.forename: Margaret E
authors.initials: ME
authors.lastname: Sherwood
authors.forename: William P
authors.initials: WP
authors.lastname: Puricelli
authors.forename: Norman S
authors.initials: NS
authors.lastname: Nishioka
authors.forename: Gregory Y
authors.initials: GY
authors.lastname: Lauwers
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D001471:Barrett Esophagus / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D001706:Biopsy; D015331:Cohort Studies; D051546:Cyclooxygenase 2 / Q000378:metabolism*; D017323:Dihematoporphyrin Ether / Q000627:therapeutic use; D004848:Epithelium / Q000378:metabolism / Q000473:pathology; D004947:Esophagus / Q000378:metabolism* / Q000473:pathology*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D010778:Photochemotherapy; D017319:Photosensitizing Agents / Q000627:therapeutic use; D012189:Retrospective Studies; D016896:Treatment Outcome
chemical_list: D017319:Photosensitizing Agents; D017323:Dihematoporphyrin Ether; D051546:Cyclooxygenase 2
references.citation: Gut. 2007 Jul;56(7):906-17
references.pmid: 17185354
references.citation: Photochem Photobiol. 1989 Sep;50(3):419-23
references.pmid: 2506587
references.citation: Cancer Res. 2002 Jul 15;62(14):3956-61
references.pmid: 12124326
references.citation: Gut. 2008 Aug;57(8):1041-8
references.pmid: 18305067
references.citation: J Biol Chem. 2003 Dec 26;278(52):52231-9
references.pmid: 14557269
references.citation: J Environ Pathol Toxicol Oncol. 2006;25(1-2):251-9
references.pmid: 16566722
references.citation: Photochem Photobiol Sci. 2007 Dec;6(12):1275-83
references.pmid: 18046482
references.citation: Br J Dermatol. 2004 Aug;151(2):472-80
references.pmid: 15327557
references.citation: J Pathol. 2005 Aug;206(4):388-94
references.pmid: 15926200
references.citation: Gastroenterology. 2002 Jun;122(7):1800-7
references.pmid: 12055587
references.citation: Gastroenterology. 2000 Sep;119(3):624-30
references.pmid: 10982754
references.citation: Cancer Res. 2006 Jun 1;66(11):5633-40
references.pmid: 16740700
references.citation: J Gastrointest Surg. 2004 Dec;8(8):1007-16; discussion 1016-7
references.pmid: 15585388
references.citation: Semin Diagn Pathol. 2002 Feb;19(1):12-9
references.pmid: 11936261
references.citation: Ann Surg. 2006 Dec;244(6):1031-6
references.pmid: 17122630
references.citation: Clin Gastroenterol Hepatol. 2008 Mar;6(3):302-8
references.pmid: 18255349
references.citation: Gastroenterology. 2002 May;122(6):1569-91
references.pmid: 12016424
references.citation: Histopathology. 2003 May;42(5):457-65
references.pmid: 12713622
references.citation: Retina. 2006 Nov-Dec;26(9):988-93
references.pmid: 17151484
references.citation: Cancer Res. 1989 Dec 15;49(24 Pt 1):6896-900
references.pmid: 2531034
references.citation: Int J Cancer. 2006 Aug 15;119(4):765-70
references.pmid: 16550596
references.citation: Am J Gastroenterol. 1999 Oct;94(10):2829-33
references.pmid: 10520829
references.citation: World J Gastroenterol. 2006 Feb 14;12(6):928-34
references.pmid: 16521222
references.citation: Am J Gastroenterol. 2001 Apr;96(4):990-6
references.pmid: 11316217
references.citation: Gastroenterology. 2002 Jul;123(1):60-7
references.pmid: 12105834
references.citation: Am J Surg Pathol. 2007 Mar;31(3):403-9
references.pmid: 17325482
references.citation: J Natl Cancer Inst. 2007 Apr 4;99(7):545-57
references.pmid: 17405999
references.citation: Dis Esophagus. 2004;17(2):136-40
references.pmid: 15230726
references.citation: Clin Cancer Res. 2006 Mar 15;12(6):1701-6
references.pmid: 16551852